The Diagnostics Pipeline: FDA Unveils Plan to End COVID-19 Test Emergency Use Authorizations
On March 27, the agency released a new guidance document to help test developers make the transition to full approval.
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article